iShares Healthcare Innovation
(DRDR)
£5.54
Previous business day’s close price
‑£1.96 (‑26.15%)
max available period
£5.25
£8.14
04 Jan 21
21 Sep 23
Details
This ETF tracks companies across the world that are focused on innovation within global healthcare services, across both developed and emerging markets, via the iSTOXX FactSet Breakthrough Healthcare index. This ETF reinvests income.
Ticker: DRDR
ISIN: IE00BYZK4776
Ticker: DRDR
ISIN: IE00BYZK4776
Key information
ETF Breakdown
argenx SE
1.7%
AMGEN Inc.
1.5%
Neurocrine Biosciences, Inc.
1.5%
Catalent Inc.
1.5%
Danaher Corp.
1.4%
Bio‑Rad Laboratories Inc.
1.4%
IQVIA
1.4%
Thermo Fisher
1.4%
Abbvie Inc
1.4%
Repligen Corp.
1.4%
Agilent Technologies Inc.
1.4%
Boston Scientific Corp.
1.4%
Seagen Inc
1.4%
Abbott Laboratories
1.3%
GSK Plc
1.3%
Charles River Laboratories International Inc.
1.3%
Intuitive Surgical Inc
1.3%
Qiagen NV
1.3%
Bio‑Techne Corp
1.3%
Genmab
1.3%
Merck&Co Inc
1.3%
Gilead Sciences, Inc.
1.3%
Medtronic Plc
1.3%
UCB SA
1.3%
BeiGene Ltd
1.2%
Sarepta Therapeutics Inc
1.2%
Hologic, Inc.
1.2%
Bristol‑Myers Squibb Co.
1.2%
Shimadzu Corporation
1.2%
Samsung Biologics Co Ltd
1.2%
Exact Sciences Corp.
1.2%
Edwards Lifesciences Corp
1.2%
Exelixis Inc
1.2%
Moderna Inc
1.2%
Pfizer Inc.
1.2%
Biogen Inc
1.1%
Medpace Holdings Inc
1.1%
Eisai Co Ltd
1.1%
Lonza Group AG
1.1%
Celltrion Inc
1.1%
Dexcom Inc
1.1%
Illumina Inc
1.1%
Natera Inc
1.0%
Bachem Holding AG
1.0%
Sysmex Corporation
1.0%
ShockWave Medical Inc
1.0%
Karuna Therapeutics Inc
1.0%
Halozyme Therapeutics Inc.
0.9%
Ionis Pharmaceuticals Inc
0.9%
Insulet Corporation
0.9%
Celltrion Health Care Co. Ltd
0.9%
Tecan Group AG
0.8%
Asahi Intecc Co. Ltd.
0.8%
Biomerieux
0.8%
10x Genomics Inc
0.8%
Maximus Inc.
0.8%
Alkermes plc
0.8%
Ipsen
0.8%
Lantheus Holdings Inc
0.8%
Intra‑Cellular Therapies Inc
0.7%
Syneos Health Us Inc
0.7%
QuidelOrtho Corporation
0.7%
Guardant Health Inc
0.7%
Siegfried Holding AG
0.6%
Immunogen, Inc.
0.6%
Evotec SE
0.6%
R1 Rcm Inc
0.6%
Acadia Pharmaceuticals Inc
0.5%
BridgeBio Pharma Inc
0.5%
Integra Lifesciences Holdings Corp
0.5%
LivaNova PLC
0.5%
Denali Therapeutics Inc
0.5%
PTC Therapeutics Inc
0.5%
Diasorin S.p.A.
0.5%
Axsome Therapeutics Inc
0.4%
Pacific Biosciences of California Inc
0.4%
Elekta AB (publ)
0.4%
Axonics Inc
0.4%
Revolution Medicines Inc
0.4%
Xenon Pharmaceuticals Inc
0.4%
Evolent Health Inc
0.4%
Pro Medicus
0.4%
Sectra Class B
0.4%
Akeso Inc
0.3%
Corvel Corp.
0.3%
NovoCure Ltd
0.3%
Atricure Inc
0.3%
Schrodinger Inc
0.3%
Mirati Therapeutics Inc
0.3%
Oxford Nanopore Technologies Plc
0.3%
SK Biopharmaceuticals Co. Ltd.
0.3%
Dynavax Technologies Corp.
0.3%
Tandem Diabetes Care Inc
0.3%
Veracyte Inc
0.3%
Apollo Medical Holdings Inc
0.3%
Bavarian Nordic A/S
0.3%
Supernus Pharmaceuticals Inc
0.3%
JEOL Ltd.
0.3%
Zealand Pharma A/S.
0.3%
MicroPort Scientific Corporation
0.3%
Galapagos NV
0.3%
Allscripts Healthcare Solutions Inc
0.2%
Catalyst Pharmaceuticals Inc
0.2%
Arvinas Operations Inc
0.2%
Beam Therapeutics Inc
0.2%
Myriad Genetics, Inc.
0.2%
Sawai Group Holdings Co Ltd
0.2%
Biocryst Pharmaceuticals Inc.
0.2%
Certara Inc
0.2%
H. Lundbeck AS
0.2%
Harmony Biosciences Holdings Inc
0.2%
PeptiDream Inc.
0.2%
SK bioscience Co. Ltd.
0.2%
TG Therapeutics Inc
0.2%
Vir Biotechnology Inc
0.2%
CompuGroup Medical SE&Co. KgaA
0.2%
Recursion Pharmaceuticals Inc
0.2%
ANI Pharmaceuticals Inc
0.2%
AbCellera Biologics Inc
0.2%
Twist Bioscience Corp
0.2%
BioArctic AB
0.2%
Chemometec AS
0.2%
Ligand Pharmaceuticals, Inc.
0.2%
Maravai LifeSciences Holdings Inc
0.2%
Neuren Pharmaceuticals Ltd
0.2%
Sage Therapeutics Inc
0.2%
Arcus Biosciences Inc
0.2%
Merus N.V
0.1%
NextGen Healthcare Inc
0.1%
Polaris Group
0.1%
Quanterix Corp
0.1%
Relay Therapeutics Inc
0.1%
Pharming Group N.V.
0.1%
Cytek BioSciences Inc
0.1%
United Laboratories International Holdings Ltd.
0.1%
Avid Bioservices Inc
0.1%
Nevro Corp
0.1%
RemeGen Co. Ltd.
0.1%
Seegene Inc
0.1%
Arcturus Therapeutics Holdings Inc
0.1%
Euroapi S.A.
0.1%
Idorsia Ltd
0.1%
Novavax, Inc.
0.1%
Regenxbio Inc
0.1%
Simulations Plus Inc.
0.1%
Ascentage Pharma Group International
0.1%
Deciphera Pharmaceuticals Inc
0.1%
Editas Medicine Inc
0.1%
ST Pharm Co Ltd
0.1%
Valneva SE
0.1%
Pharmamar S.A.
< 0.1%
Shanghai MicroPort MedBot (Group) Co.Ltd.
< 0.1%
ABL Bio Inc.
< 0.1%
Castle Biosciences Inc
< 0.1%
EOFlow Co. Ltd.
< 0.1%
Japan Lifeline Co Ltd
< 0.1%
Orasure Technologies Inc.
< 0.1%
Shinpoong Pharmaceutical
< 0.1%
4D Molecular Therapeutics Inc
< 0.1%
Allogene Therapeutics Inc
< 0.1%
Caredx Inc
< 0.1%
I‑Sens USA Inc
< 0.1%
ITeos Therapeutics Inc
< 0.1%
Lyell Immunopharma Inc
< 0.1%
PolyPeptide Group AG
< 0.1%
SD Biosensor Inc.
< 0.1%
Sartorius AG
< 0.1%
Takara Bio Inc.
< 0.1%
Adimmune Corporation
< 0.1%
Agenus Inc
< 0.1%
Alector Inc
< 0.1%
Caribou Biosciences Inc
< 0.1%
Intercept Pharmaceuticals Inc
< 0.1%
Nkmax Co. Ltd
< 0.1%
Nurix Therapeutics Inc
< 0.1%
Shanghai Junshi Biosciences Co Ltd
< 0.1%
Zymeworks Inc
< 0.1%
AnaptysBio Inc
< 0.1%
Calliditas Therapeutics AB
< 0.1%
PHC Holdings Corporation
< 0.1%
Roche Holding AG
< 0.1%
Scholar Rock Holding Corp
< 0.1%
Sillajen Biotherapeutics Inc
< 0.1%
Vanda Pharmaceuticals Inc
< 0.1%
ATAI Life Sciences N.V.
< 0.1%
Axogen Inc.
< 0.1%
CanSino Biologics Inc.
< 0.1%
Fate Therapeutics Inc
< 0.1%
Gene One Life Science
< 0.1%
Humasis Co. Ltd.
< 0.1%
Joinn Laboratories (China) Co. Ltd.
< 0.1%
Macrogenics Inc
< 0.1%
Solasto Corporation
< 0.1%
Sutro Biopharma Inc
< 0.1%
BICO Group AB
< 0.1%
Brii Biosciences Limited
< 0.1%
Eagle Pharmaceuticals Inc
< 0.1%
Hlb Therapeutics Ltd
< 0.1%
Venus Medtech (Hangzhou) Inc.
< 0.1%
Y‑Mabs Therapeutics Inc
< 0.1%
Cellivery Therapeutics Inc.
< 0.1%
Karyopharm Therapeutics Inc
< 0.1%
Mersana Therapeutics Inc
< 0.1%
Nanostring Technologies Inc
< 0.1%
Stoke Therapeutics Inc
< 0.1%
Others
0.2%
No holdings found.
Please try a different search.
Please try a different search.
North America
63.6%
Europe ex‑UK
16.3%
Japan
5.0%
Asia ex‑Japan
4.6%
UK
2.5%
Emerging Markets
0.3%
Rest of the World
5.2%
Healthcare
32.4%
Industrial
29.4%
Technology
9.4%
Financial
3.1%
Sector ‐ Other
23.2%
Why InvestEngine
Unbeatable value
Build your own portfolio commission free or leave it to our experts for just 0.25%.
Zero ISA/account charges.
Full cost details (ETF costs apply)
Zero ISA/account charges.
Full cost details (ETF costs apply)
Choice of 500+ ETFs
Low cost, diversified, index‑tracking of stock markets, bonds and commodities.
View our ETF range
View our ETF range
Actionable insights
Know exactly which companies, sectors and regions are in your portfolio.
Powerful automation
Grow your wealth the easy way with automated investing features
Easy diversification
Fractional investing lets you put as little as £1 in any ETF.
DIY or Managed
Build and manage your own portfolio or leave it to us.
